vs
Bank of Marin Bancorp（BMRC）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Bank of Marin Bancorp的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$34.1M vs $19.6M），Bank of Marin Bancorp净利率更高（24.9% vs -177.4%，领先202.3%），过去两年Bank of Marin Bancorp的营收复合增速更高（23.3% vs -12.2%）
美 洲 河 银 行 是 一 家 社 区 银 行，1983 年 由 首 任 行 长 兼 首 席 执 行 官 Robert H. Daneke 与 首 任 董 事 会 主 席 Bill L. Withrow 共 同 创 立，服 务 于 美 国 加 利 福 尼 亚 州 大 萨 克 拉 门 托 地 区。截 至 2019 年，该 行 在 北 加 州 共 运 营 十 家 网 点，提 供 企 业 及 个 人 金 融 服 务，曾 是 American River Bankshares 的 全 资 子 公 司。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BMRC vs LAB — 直观对比
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.1M | $19.6M |
| 净利润 | $8.5M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 24.9% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | 74.5% | -28.8% |
| 每股收益（稀释后） | $0.53 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $34.1M | — | ||
| Q4 25 | $27.0M | — | ||
| Q3 25 | $30.9M | $19.6M | ||
| Q2 25 | $10.3M | $21.8M | ||
| Q1 25 | $27.8M | $40.8M | ||
| Q4 24 | $22.2M | — | ||
| Q3 24 | $27.2M | $22.1M | ||
| Q2 24 | $22.5M | $22.5M |
| Q1 26 | $8.5M | — | ||
| Q4 25 | $-39.5M | — | ||
| Q3 25 | $7.5M | $-34.7M | ||
| Q2 25 | $-8.5M | $-33.5M | ||
| Q1 25 | $4.9M | $-26.0M | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $4.6M | $-26.9M | ||
| Q2 24 | $-21.9M | $-45.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% |
| Q1 26 | — | — | ||
| Q4 25 | -212.6% | — | ||
| Q3 25 | 31.1% | -168.5% | ||
| Q2 25 | -108.8% | -118.1% | ||
| Q1 25 | 23.3% | -80.8% | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 25.7% | -120.9% | ||
| Q2 24 | -153.0% | -134.5% |
| Q1 26 | 24.9% | — | ||
| Q4 25 | -146.5% | — | ||
| Q3 25 | 24.3% | -177.4% | ||
| Q2 25 | -82.9% | -153.7% | ||
| Q1 25 | 17.5% | -63.8% | ||
| Q4 24 | 27.1% | — | ||
| Q3 24 | 16.8% | -122.0% | ||
| Q2 24 | -97.5% | -203.3% |
| Q1 26 | $0.53 | — | ||
| Q4 25 | $-2.48 | — | ||
| Q3 25 | $0.47 | $-0.09 | ||
| Q2 25 | $-0.53 | $-0.09 | ||
| Q1 25 | $0.30 | $-0.07 | ||
| Q4 24 | $0.38 | — | ||
| Q3 24 | $0.28 | $-0.07 | ||
| Q2 24 | $-1.36 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $394.5M | $399.7M |
| 总资产 | $3.9B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M |
| Q1 26 | $394.5M | — | ||
| Q4 25 | $394.7M | — | ||
| Q3 25 | $443.8M | $399.7M | ||
| Q2 25 | $438.5M | $424.5M | ||
| Q1 25 | $439.6M | $454.6M | ||
| Q4 24 | $435.4M | — | ||
| Q3 24 | $437.0M | $489.3M | ||
| Q2 24 | $434.9M | $510.3M |
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | $539.6M | ||
| Q2 25 | $3.7B | $557.0M | ||
| Q1 25 | $3.8B | $579.6M | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.8B | $681.5M | ||
| Q2 24 | $3.7B | $708.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $39.1M | — | ||
| Q3 25 | $12.5M | $-22.2M | ||
| Q2 25 | $8.0M | $-20.7M | ||
| Q1 25 | $4.9M | $-30.3M | ||
| Q4 24 | $28.4M | — | ||
| Q3 24 | $9.9M | $-27.9M | ||
| Q2 24 | $3.4M | $-39.0M |
| Q1 26 | — | — | ||
| Q4 25 | $37.3M | — | ||
| Q3 25 | $12.1M | $-23.1M | ||
| Q2 25 | $7.1M | $-22.6M | ||
| Q1 25 | $4.6M | $-35.3M | ||
| Q4 24 | $27.8M | — | ||
| Q3 24 | $9.8M | $-30.1M | ||
| Q2 24 | $3.4M | $-41.0M |
| Q1 26 | — | — | ||
| Q4 25 | 138.1% | — | ||
| Q3 25 | 39.0% | -118.1% | ||
| Q2 25 | 68.7% | -103.6% | ||
| Q1 25 | 16.6% | -86.6% | ||
| Q4 24 | 125.7% | — | ||
| Q3 24 | 36.0% | -136.4% | ||
| Q2 24 | 15.0% | -182.2% |
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | — | ||
| Q3 25 | 1.3% | 4.5% | ||
| Q2 25 | 9.4% | 8.7% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.4% | 10.2% | ||
| Q2 24 | 0.4% | 8.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.66× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 4.73× | — | ||
| Q3 24 | 2.16× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMRC
| Net Interest Income | $30.3M | 89% |
| Noninterest Income | $3.8M | 11% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
